Related Experiment Video
Updated: Aug 10, 2026

07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 16, 2010
Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation
The Journal of Clinical Endocrinology and Metabolism
|February 7, 2004
Summary
Low adiponectin levels are linked to poorer endothelial function, independent of diabetes. This suggests adiponectin plays a role in vascular health by influencing blood vessel dilation.
Area of Science:
- Cardiovascular Research
- Metabolic Syndrome
- Endocrinology
Background:
- Adiponectin, an adipokine, is implicated in antiatherogenic effects by modulating endothelial activation.
- Endothelial dysfunction is a key factor in the development of atherosclerosis.
- Understanding the relationship between adiponectin and endothelial function is crucial for cardiovascular health.
Purpose of the Study:
- To investigate the correlation between plasma adiponectin levels and endothelial function in type 2 diabetic patients and healthy controls.
- To determine if diabetes mellitus influences the association between adiponectin and endothelial function.
- To explore the in vitro mechanisms by which adiponectin affects endothelial cells.
Main Methods:
- Plasma adiponectin levels were measured using radioimmunoassay (RIA).
- Endothelium-dependent and independent vasodilation were assessed via high-resolution vascular ultrasound of the brachial artery.
- In vitro studies examined adiponectin receptor expression and nitric oxide production in human aortic endothelial cells.
Main Results:
- Diabetic patients exhibited significantly lower plasma adiponectin levels compared to controls.
- Impaired endothelium-dependent and independent vasodilation was observed in diabetic patients.
- Plasma adiponectin levels positively correlated with endothelium-dependent vasodilation in both groups.
- Plasma adiponectin was identified as an independent determinant of endothelium-dependent vasodilation, alongside brachial artery diameter, diabetes status, and high-density lipoprotein levels.
- In vitro, adiponectin treatment increased nitric oxide production in human aortic endothelial cells.
Conclusions:
- Low plasma adiponectin levels are associated with impaired endothelium-dependent vasodilation.
- This association is independent of the presence of diabetes mellitus.
- Adiponectin may serve as a crucial link between adipose tissue and vascular health, potentially through its effects on nitric oxide production.
More Related Videos
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

